TRiCBIO brings together expertise in target discovery, organoid science and clinical pharmacology. The right scientific lead joins each study to guide model selection, study design and interpretation.
TRiCBIO team | from scientific planning to study delivery
How the team works with you
Scientific guidance from study design through delivery
Scientific leads shape model selection, study design and interpretation, while the project team coordinates laboratory execution, data review, reporting and follow-up recommendations.
Wei He, PhD brings oncology target-discovery and functional-genomics experience from Novartis. He connects human organoids, functional screening and drug development to target prioritization, candidate evaluation and next-stage decisions.
BS, Peking University; PhD, The Ohio State University
Biopharma experience in target discovery and functional genomics
Advances human models into drug-discovery workflows
Leads company strategy, translation and global coordination
Chief Scientist & Chief Technology Officer
Xingnan Li, PhD
ALI organoids, tumor biology & platform science
Xingnan Li, PhD co-developed the ALI tumor-immune organoid method and was a co-first author of the 2018 Cell study. Her work informs TRiCBIO's PDO 2.0 model design, assay strategy and result interpretation.
PhD, University of Alabama; postdoctoral fellow and research lecturer, Stanford University School of Medicine
Co-developer of ALI patient-derived tumor organoids
Co-first author of the 2018 Cell paper
Leads PDO 2.0 scientific strategy and platform development
David Yin, PhD brings oncology clinical-pharmacology experience from Novartis to client organoid programs. He supports cross-regional study design, including endpoint and control selection, data interpretation and planning for translational follow-up.
MS, University of Science and Technology of China; PhD in Molecular and Cellular Biology and MS in Biostatistics, The Ohio State University
Oncology clinical-pharmacology and project experience in global biopharma
Background in study design and data analysis
Coordinates project operations and cross-regional collaboration
How the project team works together
A coordinated team for each study
01
Scientific planning
Match models and readouts to the study objective
02
Study management
Keep scope, milestones, materials and communication on track
03
Laboratory research
Run cultures, treatments and assays to the agreed protocol
04
Quality & reporting
Review model QC and results and prepare the study report
05
Bilingual communication
Provide project discussion and feedback in Chinese or English
Your cross-functional project team
The core team spans target discovery, functional genomics, organoid models, tumor biology and biopharma R&D. Model, assay and project specialists work together from scientific planning through experimental execution, data review and delivery.
TRiCBIO brings together expertise in target discovery, organoid science and clinical pharmacology. The right scientific lead joins each study to guide model selection, study design and interpretation.
TRiCBIO team | from scientific planning to study delivery
How the team works with you
Scientific guidance from study design through delivery
Scientific leads shape model selection, study design and interpretation, while the project team coordinates laboratory execution, data review, reporting and follow-up recommendations.
Wei He, PhD brings oncology target-discovery and functional-genomics experience from Novartis. He connects human organoids, functional screening and drug development to target prioritization, candidate evaluation and next-stage decisions.
BS, Peking University; PhD, The Ohio State University
Biopharma experience in target discovery and functional genomics
Advances human models into drug-discovery workflows
Leads company strategy, translation and global coordination
Chief Scientist & Chief Technology Officer
Xingnan Li, PhD
ALI organoids, tumor biology & platform science
Xingnan Li, PhD co-developed the ALI tumor-immune organoid method and was a co-first author of the 2018 Cell study. Her work informs TRiCBIO's PDO 2.0 model design, assay strategy and result interpretation.
PhD, University of Alabama; postdoctoral fellow and research lecturer, Stanford University School of Medicine
Co-developer of ALI patient-derived tumor organoids
Co-first author of the 2018 Cell paper
Leads PDO 2.0 scientific strategy and platform development
David Yin, PhD brings oncology clinical-pharmacology experience from Novartis to client organoid programs. He supports cross-regional study design, including endpoint and control selection, data interpretation and planning for translational follow-up.
MS, University of Science and Technology of China; PhD in Molecular and Cellular Biology and MS in Biostatistics, The Ohio State University
Oncology clinical-pharmacology and project experience in global biopharma
Background in study design and data analysis
Coordinates project operations and cross-regional collaboration
How the project team works together
A coordinated team for each study
01
Scientific planning
Match models and readouts to the study objective
02
Study management
Keep scope, milestones, materials and communication on track
03
Laboratory research
Run cultures, treatments and assays to the agreed protocol
04
Quality & reporting
Review model QC and results and prepare the study report
05
Bilingual communication
Provide project discussion and feedback in Chinese or English
Your cross-functional project team
The core team spans target discovery, functional genomics, organoid models, tumor biology and biopharma R&D. Model, assay and project specialists work together from scientific planning through experimental execution, data review and delivery.
